NCT04323839

COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

PRIORITY (Pregnancy Coronavirus Outcomes Registry)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,333 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: Female
• Age: 13 Years
• Healthy volunteers: Not accepted

Summary

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

Detailed description

The investigators will recruit women age 13 or older under investigation for COVID-19 or with confirmed COVID-19 at any clinical state across the United States. Eligible participants will be identified through voluntary physician referrals. When an eligible patient is referred to the PRIORITY Coordinating Center at UCSF, a UCSF study coordinator will follow-up by phone with the patient and consent verbally. The participant will be asked to complete an approval to release medical information. The investigators will use patient questionnaires to assess symptoms, maternal clinical course, pregnancy outcomes, and neonatal outcomes from initial investigation of COVID-19 to 12 months. The investigators will also obtain all medical records for the participant to data abstract key clinical and pregnancy outcomes.

Conditions

• Pregnancy
• Coronavirus
• COVID-19

Interventions

Type	Name	Description
OTHER	Pregnant women under investigation for Coronavirus or diagnosed with COVID-19	This is an observational study with no intervention
OTHER	Postpartum women under investigation for Coronavirus or diagnosed with COVID-19	This is an observational study with no intervention

Timeline

• Start date: 2020-03-20
• Primary completion: 2022-04-26
• Completion: 2022-04-26
• First posted: 2020-03-27
• Last updated: 2024-05-08

Locations

1 site across 1 country: United States